• Join
  • Login
  • Contact

Search abstracts / presentations

The United States pharmacopeia drug quality and information program (usp dqi) develops and disseminates evidence-based drug information

  • In: Current Issues in drug and healthcare information (Pharmacy Information Section) on Thursday, 9 September 2004, 14:00-17:00
  • At: New Orleans (USA) (2004)
  • Type: Presentation
  • By: SEYOUM, Daniel (The United States Pharmacopeia, Global Assistance Initiatives, Rockville, United States of America)
  • Co-author(s): Blum (The United States Pharmacopeia, Rockville, United States of America)
  • Abstract:

    Background: USP promotes the public health by establishing and disseminating authoritative information for the use of medicines by health care professionals, patients, and consumers. The USP DQI Program, a five-year cooperative agreement between the USP and the USAID, supports the delivery of USAID priority interventions such as improving


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses